12/11/2023 | 3002150000 | MEDICINE FOR RETAIL SALE, (VED. V1): HERCEPTIN (TRASTUZUMAB) [LYOPHILIZATE FOR PREPARATION OF CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSION, | XXXXXXXXXX | 0 | N/A | 2622571 | United States | MOSCOW |
12/8/2023 | 3002150000 | MEDICINES FOR RETAIL SALE:(VED V1)ORENCIA(ABATACEPT) [LYOPHILIZATE FOR PREPARATION OF CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSION, 250 MG (BOTTLE) X 1+SILICONE FREE SYRINGE X | XXXXXXXXXX | 0 | N/A | 381266 | United States | LESHKOVO |
12/8/2023 | 3002150000 | MEDICINES FOR RETAIL SALE:(VED V1)ORENCIA(ABATACEPT) [LYOPHILIZATE FOR PREPARATION OF CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSION, 250 MG (BOTTLE) X 1+SILICONE FREE SYRINGE X | XXXXXXXXXX | 0 | N/A | 380961 | United States | LESHKOVO |
12/8/2023 | 3002150000 | MEDICINES FOR RETAIL SALE:(VED V1)ORENCIA(ABATACEPT) [LYOPHILIZATE FOR PREPARATION OF CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSION, 250 MG (BOTTLE) X 1+SILICONE FREE SYRINGE X | XXXXXXXXXX | 0 | N/A | 609873 | United States | LESHKOVO |
12/5/2023 | 3002150000 | MEDICINE FOR RETAIL SALE, (VED, V1): HERCEPTIN (TRASTUZUMAB) [LYOPHILIZATE FOR PREPARATION OF CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSION, 440 MG (BOTTLE) X | XXXXXXXXXX | 0 | N/A | 6901566 | United States | MOSCOW |
12/5/2023 | 3002150000 | MEDICINE FOR RETAIL SALE, (VED, V1): MABTHERA (RITUXIMAB) CONCENTRATE FOR PREPARATION OF SOLUTION FOR INFUSION, | XXXXXXXXXX | 0 | N/A | 85695 | Germany | MOSCOW |
12/5/2023 | 3002150000 | MEDICINE FOR RETAIL SALE: MABTHERA (RITUXIMAB) SOLUTION FOR SUBCUTANEOUS IV | XXXXXXXXXX | 0 | N/A | 964112 | Switzerland | MOSCOW |
12/5/2023 | 3002150000 | MEDICINAL PRODUCT FOR RETAIL SALE: ENSPRINGR (SATRALIZUMAB) SOLUTION FOR SUBCUTANEOUS ADMINISTRATION 120 MG/M | XXXXXXXXXX | 0 | N/A | 326029 | Japan | MOSCOW |
11/29/2023 | 3002150000 | MEDICINAL PRODUCTS FOR RETAIL SALE: VISQUIU (BROLUCIZUMAB) [INTRAOCULAR SOLUTION | XXXXXXXXXX | 0 | N/A | 4293559 | Switzerland | MOSCOW |
11/28/2023 | 3002150000 | UNREGISTERED MEDICAL DRUG, KRISVITA (BUROSUMAB), SOLUTION FOR HYPOCUTANEOUS INJECTION, 30 MG/ML, 1ML, No. 1, SERIES A22101YU04, EXPIRED 08/31/2024, PREFERRED, FOR PROVIDING. HONEY. HELP ON LIFE. CONC.PATIENT,UP. IN ONE THERMAL CONTAINER WITH COOLING ELEME | XXXXXXXXXX | 0 | N/A | 2841686 | Germany | MOSCOW |